- Altarex Corp.
Focused on photoactivation and multi-epitopic development of foreign antibodies that activate and modulate the immune system for the treatment of ovarian tumors and multiple myeloma. Profile of company, clinic and science, with investor data and contacts at University of Alberta, Edmonton, Canada.
http://www.altarex.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Australian Cancer Technology Pty Ltd
Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia.
http://www.austcancer.com.au/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Bath Cancer Research
Offers cytotoxicity screening for potential drugs, and ex vivo drug sensitivity cell testing, for non-Hodgkin's lymphoma, chronic and acute leukaemias, to haematologists and oncologists, as an international service from Bath, UK.
http://www.caltri.org/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Biomoda, Inc.
Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico.
http://www.biomoda.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Celtic Biotech, Inc.
Develops products from the proof of concept stage to clinically viable in vitro diagnostics, in the fields of oncology and immunology. Includes patents, related publication list and profile of company in Utah.
http://www.celticbio.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Crusade Laboratories Ltd.
Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK.
http://www.crusadelabs.co.uk/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Dominion Pharmakine
Preclinical-stage biopharmaceutical company that designs, develops and commercializes technologies for cancer metastasis research and treatment. Worldwide news, products and contacts in Bizkaia, Spain.
http://www.pharmakine.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - GeneSegue
Focusing on the development of delivery systems to target solid tumors, such as prostate with nanoencapsulated biotherapeutics. Includes brief overview of concepts from Chaska, Minnesota.
http://www.genesegues.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Hannah Cell Science
Offer analytical services and research partnerships in cell biology focusing on mammalian mammary gland, with applications in breast cancer and lactation. Includes examples of cytotoxicity screening, phenotyping, molecular interactions and binding studies in Ayr, Scotland.
http://www.hannahcellscience.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - InterGenetics Inc.
Company with platform technology, called CombiSNiP, that genetically quantifies an individual’s risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City.
http://www.intergenetics.com/index1.html
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Karyon
Offers products in angiogenesis and cell growth regulation, focusing on protected ligands that target specifically to sarcomas and melanomas. Includes research and technology overview, and information for investors in Helsinki, Finland.
http://www.karyon.fi/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - Onyvax Ltd.
Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK.
http://www.onyvax.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It - PNP Therapeutics, Inc.
Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumour cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.
http://www.pnptherapeutics.com/
(Added: Thu Jan 01 2004 Hits: 0 Rating: 0.00 Votes: 0)
Rate It
Review It |
